TOPIC TAGS for this article:
Pharma + Biotech, Litigation
Click on a topic to display all headlines on that subject
SSJR Successfully Defends Daubert Motion Enabling Expert Witness to Testify at Trial
12 May 2015
SSJR successfully defended a Daubert Motion jointly filed by Plaintiff and Third-Party Defendants in a complex contract dispute that SSJR is defending for its client, ChemWerth, Inc. The Court ruled that ChemWerth’s expert witness is allowed to testify at trial on all topics in his expert report. ChemWerth is a full service generic drug development and supply company founded by Peter J. Werth, Jr. that provides high quality Active Pharmaceutical Ingredients to regulated markets worldwide.